Quantcast

Latest Surgical oncology Stories

2014-04-24 23:10:58

The latest study to compare the two major surgical approaches to mesothelioma says the more radical approach is “an independent predictor” for complications and even death. (PRWEB) April 24, 2014 Thoracic surgeons and biostatisticians from some of the country’s top research centers say extrapleural pneumonectomy, the most invasive surgical treatment for pleural mesothelioma, is more likely to cause serious problems for patients. Click here to read the story, which has just been...

2014-04-24 08:32:37

Latest Data Sweep from Large Subgroup of Patients Shows a Strong 50% Improvement in Overall Survival for ThermoDox® LAWRENCEVILLE, N.J., April 24, 2014 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN) today announced that updated results from the 701 patient HEAT Study post-hoc analysis, as well as a review of the final study design of the Phase III OPTIMA Study, which both explore ThermoDox®, Celsion's proprietary heat-activated liposomal encapsulation of doxorubicin, in...

2014-04-18 23:02:14

In Wake of Morcellation Lawsuit FDA Calls For Termination of Procedures Using Laparoscopic Power Morcellation That Allegedgly Causes Leiomyosarcoma, reports Alonso Krangle LLP New York, NY (PRWEB) April 18, 2014 The U.S. Food and Drug Administration (FDA) warned Thursday against using laparoscopic power morcellation during gynecological surgeries on women because the procedure can potential cause the spread uterine cancer in the abdomen and pelvis. The FDA estimates that one in 350 women...

2014-04-16 23:13:08

Managing an effective network of 2,500 medical experts requires constant revisions, alterations and updates. Mednick Associates recently added orthopedic surgeon experts and oncology experts to their extensive physician expert network to continue to meet client needs. Wilton, CT (PRWEB) April 16, 2014 Providing medical experts to litigators across the nation for over 20 years, Mednick Associates currently grants clients access to 2,500 medical expert witnesses. With an exclusive focus on...

2014-04-10 08:30:03

Professor Riccardo Lencioni is giving an honorary lecture on April 24, 2014 which will highlight the latest findings and lessons learned from the HEAT Study and the design of the Phase III OPTIMA Study LAWRENCEVILLE, N.J., April 10, 2014 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN) announced today that Professor Riccardo Lencioni, MD, FSIR, EBIR, Professor and Director of the Diagnostic Imaging and Intervention at the Pisa University School of Medicine in Italy, former ECIO President,...

2014-04-04 23:34:52

Cianna Medical, Inc.: Strut-based breast cancer radiation treatment could expand options for DCIS patients. Aliso Viejo, Calif. (PRWEB) April 03, 2014 Cianna Medical, Inc., a women’s health company, today announced the results of a retrospective study of breast cancer patients with ductal carcinoma in situ (DCIS) treated with SAVI® breast brachytherapy. Researchers reported excellent local control, with recurrence rates that appear to be equivalent to those expected for whole...

2014-04-01 23:27:44

Complaint Alleges Defendants Failed to Warn the Decedent that the Use of Morcellator During Her Hysterectomy Could Result in Seeding of Undiagnosed Sarcoma Through the Peritoneal Cavity New York, NY (PRWEB) April 01, 2014 The widow of a Pennsylvania woman who died from metastatic myleosarcoma has filed a morcellation cancer lawsuit alleging that her death was the result of uterine morcellation. According to the complaint, the use of a morcellator, a device used to remove tissue during...

2014-04-01 23:23:02

BroadcastMed, Inc. announces the expansion of the BroadcastMed Network’s specialty specific clinical content with the launch of the OBGYN Channel. Farmington, CT (PRWEB) April 01, 2014 BroadcastMed, Inc. announces the expansion of the BroadcastMed Network’s specialty specific clinical content with the launch of the Obstetrics and Gynecology (OBGYN) Channel. The channel will offer open access to the latest obstetrics and gynecology procedures from world renowned physicians and...

2014-03-31 08:29:52

Defitelio®? (defibrotide) Launch Announced During the 40th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) 2014 DUBLIN and VILLA GUARDIA, Italy, March 31, 2014 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and Gentium S.p.A., a Jazz Pharmaceuticals company, today announced the commencement of the European commercial launch of Defitelio®(?) (defibrotide), the first licensed product for the treatment of severe hepatic veno-occlusive...

2014-03-27 23:25:30

British researchers say cordotomy may be a safe and effective option for patients experiencing severe mesothelioma pain. Raleigh, NC (PRWEB) March 27, 2014 In a study published in BMJ Supportive and Palliative Care and recently posted on the Surviving Mesothelioma website, British researchers say a spinal procedure called cordotomy may relieve the pain of late-stage pleural mesothelioma. Click here to read the study details. Scientists at the North Wales Centre for Primary Care Research...


Word of the Day
barghest
  • A goblin in English folklore, often appearing in the shape of a large dog and believed to portend imminent death or misfortune.
  • A ghost, wraith, hobgoblin, elf, or spirit.
The origin of 'barghest' is not known, but it may be from perhaps burh-ghest, town-ghost, or German Berg-geist (mountain spirit) or Bär-geist (bear-spirit).
Related